GlycoEra AG
Schlieren, Switzerland ยท Science and Engineering
This profile has not been verified by the business owner.
Information may be incomplete or outdated.
Overview
GlycoEra is positioned as the leading precision protein degradation company. Bifunctional biologics (G-LyTACs), designed by our novel and proprietary technology bind to disease-causing proteins and transport them to the lysosome using naturally occurring endocytic receptors. The disease-causing proteins are degraded in the lysosome and removed from the body. Unlike intracellular protein degraders, like PROTACs and molecular glues, our technology can access targets that are extracellular and membrane proteins, thereby opening up novel targets and therapeutic areas for intervention.
Contact Details
info@glycoera.com
Schlieren, Switzerland
Founded
2020
Employees
20-30
Categories
Keywords
#Glycoengineering
#Therapeutic product development
#Biopharmaceutical CMC development
Companies teams usually look at after GlycoEra AG
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.